Promising approaches for treatment and prevention of viral respiratory illnesses

Autor: Nikolaos G. Papadopoulos, Olympia Vangelatou, Paraskevi Xepapadaki, Nikolaos A. Kitsioulis, Spyridon Megremis, Peter W. West
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
SARS
Severe acute respiratory syndrome

Rhinovirus
natural products
respiratory syncytial virus
viruses
vRTI
Viral respiratory tract infection

medicine.disease_cause
SPM
Specialized proresolving lipid mediator

Viral Respiratory Tract Infection
vaccine
Immunology and Allergy
VLP
Virus-like particle

PIV
Parainfluenza Virus

Respiratory Tract Infections
Respiratory tract infections
biology
Neuraminidase inhibitor
Viral Vaccine
public health
Common cold
Orthomyxoviridae
antiviral
Respiratory Syncytial Viruses
3. Good health
Virus Diseases
RSV
Respiratory syncytial virus

bronchiolitis
NAI
Neuraminidase inhibitor

Immunotherapy
TLR
Toll-like receptor

medicine.drug_class
ICAM-1
Intercellular adhesion molecule 1

Immunology
monoclonal
COPD
Chronic obstructive pulmonary disease

RTI
Respiratory tract infection

Mass Vaccination
Article
03 medical and health sciences
medicine
Animals
Humans
IFV
Influenza virus

Viral Vaccines
medicine.disease
biology.organism_classification
common cold
Influenza
030104 developmental biology
Bronchiolitis
HA
Hemagglutinin
Zdroj: Megremis, S, Papadopoulos, N, Kitsioulis, N A, Vangelatou, O, West, P & Xepapadaki, P 2017, ' Promising approaches for treatment and prevention of viral respiratory illnesses ', Journal of Allergy and Clinical Immunology . https://doi.org/10.1016/j.jaci.2017.07.001
The Journal of Allergy and Clinical Immunology
DOI: 10.1016/j.jaci.2017.07.001
Popis: Viral respiratory tract infections are the most common human ailments, leading to enormous health and economic burden. Hundreds of viral species and subtypes have been associated with these conditions, with influenza viruses, respiratory syncytial virus, and rhinoviruses being the most frequent and with the highest burden. When considering prevention or treatment of viral respiratory tract infections, potential targets include the causative pathogens themselves but also the immune response, disease transmission, or even just the symptoms. Strategies targeting all these aspects are developing concurrently, and several novel and promising approaches are emerging. In this perspective we overview the entire range of options and highlight some of the most promising approaches, including new antiviral agents, symptomatic or immunomodulatory drugs, the re-emergence of natural remedies, and vaccines and public health policies toward prevention. Wide-scale prevention through immunization appears to be within reach for respiratory syncytial virus and promising for influenza virus, whereas additional effort is needed in regard to rhinovirus, as well as other respiratory tract viruses.
Databáze: OpenAIRE